These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27237820)

  • 1. Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
    Giaginis C; Lakiotaki E; Korkolopoulou P; Konstantopoulos K; Patsouris E; Theocharis S
    Curr Med Chem; 2016; 23(22):2350-62. PubMed ID: 27237820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approaches.
    Ortega-Gutiérrez S; López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):651-8. PubMed ID: 16026311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.
    Westphal MV; Sarott RC; Zirwes EA; Osterwald A; Guba W; Ullmer C; Grether U; Carreira EM
    Chemistry; 2020 Jan; 26(6):1380-1387. PubMed ID: 31961047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preface.
    Methods Enzymol; 2017; 593():xvii-xxiv. PubMed ID: 28750818
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
    Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
    Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.
    Latini L; Bisicchia E; Sasso V; Chiurchiù V; Cavallucci V; Molinari M; Maccarrone M; Viscomi MT
    Cell Death Dis; 2014 Sep; 5(9):e1404. PubMed ID: 25188514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.
    Nadipuram AK; Krishnamurthy M; Ferreira AM; Li W; Moore BM
    Bioorg Med Chem; 2003 Jul; 11(14):3121-32. PubMed ID: 12818675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioisosteric concept applied to cannabinoid ligands.
    Mugnaini C; Pasquini S; Corelli F
    Curr Med Chem; 2012; 19(28):4794-815. PubMed ID: 22830341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
    Greenhough A; Patsos HA; Williams AC; Paraskeva C
    Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis.
    Silva JP; Carmo H; Carvalho F
    Toxicol Lett; 2018 May; 287():59-69. PubMed ID: 29410032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.
    Dobrosi N; Tóth BI; Nagy G; Dózsa A; Géczy T; Nagy L; Zouboulis CC; Paus R; Kovács L; Bíró T
    FASEB J; 2008 Oct; 22(10):3685-95. PubMed ID: 18596221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB
    Soethoudt M; Grether U; Fingerle J; Grim TW; Fezza F; de Petrocellis L; Ullmer C; Rothenhäusler B; Perret C; van Gils N; Finlay D; MacDonald C; Chicca A; Gens MD; Stuart J; de Vries H; Mastrangelo N; Xia L; Alachouzos G; Baggelaar MP; Martella A; Mock ED; Deng H; Heitman LH; Connor M; Di Marzo V; Gertsch J; Lichtman AH; Maccarrone M; Pacher P; Glass M; van der Stelt M
    Nat Commun; 2017 Jan; 8():13958. PubMed ID: 28045021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
    Dixon DD; Tius MA; Thakur GA; Zhou H; Bowman AL; Shukla VG; Peng Y; Makriyannis A
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5322-5. PubMed ID: 22796181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
    Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
    J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological basis of cannabinoid medicines.
    Keimpema E; Di Marzo V; Harkany T
    Science; 2021 Dec; 374(6574):1449-1450. PubMed ID: 34914498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
    McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
    Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.